Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England

PURPOSE: Chronic obstructive pulmonary disease (COPD) exacerbations are associated with significant morbidity and mortality and increased economic healthcare burden for patients with COPD. Long-acting muscarinic antagonist (LAMA)/long-acting β(2)-agonist (LABA) dual therapy is recommended for patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Requena, Gema, Czira, Alexandrosz, Banks, Victoria, Wood, Robert, Tritton, Theo, Castillo, Catherine, Yeap, Jie, Wild, Rosie, Compton, Chris, Rothnie, Kieran J, Herth, Felix J F, Quint, Jennifer K, Ismaila, Afisi S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508247/
https://www.ncbi.nlm.nih.gov/pubmed/37731774
http://dx.doi.org/10.2147/COPD.S408688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508247/
https://www.ncbi.nlm.nih.gov/pubmed/37731774
http://dx.doi.org/10.2147/COPD.S408688

Ejemplares similares